On September 30, 2019, the Centers for Medicare & Medicaid Services (“CMS”) published notice of a proposed survey (“Survey”) of drug acquisition costs for all hospitals participating in the 340B drug discount program (“340B Program”). The Survey would require reporting of acquisition cost data on 340B discounted drugs, referred to as specified covered outpatient... READ MORE
Proposed CMS Hospital Survey Could Support CMS’s Efforts to Reduce 340B Drug Reimbursement
Posted on October 7, 2019 in Health Law News
Published by: Hall Render
